ARCHIVES

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

This article is from The Cancer Letter archive.

Vol. 08 No. 24 | June 11, 1982

Download PDF Visit The Full Archive

Related Articles

Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015.

November 23, 2005

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002

In Brief: Gertrude Elion, Nobel Laureae Whose Work Led To New Drugs For Cancer, Dead at 81

February 26, 1999

Maguire Backs Cancer Program But Insists On New Emphasis for Prevention

January 26, 1979

Counseling reduces Pain, Study Shows

April 18, 1986

FDA Grants Accelerated Approval To Ferriprox for Iron Overload

October 28, 2011